Antimicrobial Agents and Chemotherapy

It’s vital to optimize use of antimicrobials Optimize antimicrobial use to confirm effectiveness whereas minimizing resistance development in common community-acquired infections Identify management ways to stop, or minimize clinically important drug interactions with common antimicrobials. Safety and effectiveness of intravenous iron in patients with chemotherapyelicited anaemia receiving darbepoetin alpha Effects of endogenous (IV) iron supplementation on responses to every-three-week (Q3W) darbepoetin alpha (DA) by baseline haemoglobin in patients (pts.) with chemotherapy-induced anemia (CIA)1 A phase III clinical trial randomised controlled study comparison iron saccharose intravenously (IV) to no iron treatment of anemia in cancer patients undergoing therapy and glycoprotein stimulating agent (ESA) therapy Improvement in quality of life precedes increase in haemoglobin levels upon treatment with intravenous iron and epoetin alpha.

 

    Related Conference of Antimicrobial Agents and Chemotherapy

    May 10-11, 2021

    4th Global Experts Meeting on Infectious Diseases

    Singapore City, Singapore
    August 16-17, 2021

    13th Global Infections Conference

    Tokyo, Japan
    September 06-07, 2021

    11th World Congress on Rare Diseases and Orphan Drugs

    Berlin, Germany

    Antimicrobial Agents and Chemotherapy Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in